Cardiac Effects of a Single Dose of Pimobendan in Cats With Hypertrophic Cardiomyopathy; A Randomized, Placebo-Controlled, Crossover Study

Background: Pimobendan has been shown to impart a significant survival benefit in cardiomyopathic cats who receive it as part of heart failure therapy. However, use of pimobendan remains controversial in cats with hypertrophic cardiomyopathy (HCM) due to lack of pharmacodynamic data for pimobendan i...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Vet Sci
Glavni autori: Oldach, Maureen S., Ueda, Yu, Ontiveros, Eric S., Fousse, Samantha L., Harris, Samantha P., Stern, Joshua A.
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Veterinary Science
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6369151/
https://ncbi.nlm.nih.gov/pubmed/30778391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fvets.2019.00015
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items